An exploratory investigation of endotoxin levels in novice long distance triathletes,and the effects of a multi-strain probiotic/prebiotic,antioxidant intervention

Nutrients

Volumn 8, Issue 11, 2016, Pages

  Roberts, Justin D ^a   Suckling, Craig A ^a   Peedle, Georgia Y ^a   Murphy, Joseph A ^b   Dawkins, Tony G ^c   Roberts, Michael G ^b  

^a ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Antioxidants; Endotoxemia; Prebiotics; Probiotics; Triathlon

Indexed keywords

CARBOHYDRATE; ENDOTOXIN; LIPOPOLYSACCHARIDE; PROBIOTIC AGENT; PROTEIN; ANTIOXIDANT; BIOLOGICAL MARKER; CARNOSINE; DRUG COMBINATION; MICROCAPSULE; N-ACETYLCARNOSINE; PREBIOTIC AGENT; THIOCTIC ACID;

ADULT; ANTHROPOMETRY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHLETE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BODY FAT; CALCULATION; CALORIC INTAKE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTERVENTION STUDY; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS ACIDOPHILLUS; LACTOBACILLUS ACIDOPHILUS; LIMIT OF QUANTITATION; MALE; MIDDLE AGED; NORMAL HUMAN; NUTRITIONAL ASSESSMENT; OXYGEN CONSUMPTION; PERMEABILITY; PROTEIN INTAKE; PROTEIN PHOSPHORYLATION; TRAINING; YOUNG ADULT; ANALOGS AND DERIVATIVES; BACTERIAL TRANSLOCATION; BLOOD; CONTROLLED STUDY; CYCLING; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECTS; ENDOTOXEMIA; ENDURANCE; ENGLAND; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; INTESTINE FLORA; MICROBIOLOGY; MICROCAPSULE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RUNNING; SWIMMING; TIME FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTIOXIDANTS; BACTERIAL TRANSLOCATION; BICYCLING; BIOMARKERS; CAPSULES; CARNOSINE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ENDOTOXEMIA; ENDOTOXINS; ENGLAND; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; MALE; PHYSICAL ENDURANCE; PREBIOTICS; PROBIOTICS; RUNNING; SWIMMING; THIOCTIC ACID; TIME FACTORS; TREATMENT OUTCOME;

EID: 84996602316     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8110733     Document Type: Article

References (73)

1. Da Fonseca-Engelhardt,K.; Knechtle,B.; Rüst,C.A.; Knechtle,P.; Lepers,R.; Rosemann,T. Participation and performance trends in ultra-endurance running races under extreme conditions-‘Spartathlon’ versus ‘Badwater’. Extreme Physiol. Med. 2013,2,15. [CrossRef] [PubMed]
2. Hoffman,M.D. Performance trends in 161-km ultramarathons. Int. J. Sports Med. 2010,31,31-37. [CrossRef] [PubMed]
3. De Oliveira,E.P.; Burini,R.C.; Jeukendrup,A. Gastrointestinal complaints during exercise: Prevalence,etiology,and nutritional recommendations. Sports Med. 2014,44 (Suppl. 1),S79-S85. [CrossRef] [PubMed]
4. Ten Haaf,D.S.M.; van der Worp,M.P.; Groenewould,H.M.M.; Leij-Halfwerk,S.; Nijhuis-van der Sanden,M.W.G.; Verbeek,A.L.M.; Staal,J.B. Nutritional indicators for gastrointestinal symptoms in female runners: The ‘Marikenloop study’. BMJ Open 2014,4,e005780. [CrossRef] [PubMed]
5. Stuempfle,K.; Hoffman,M.D. Gastrointestinal distress is common during a 161-km ultramarathon. J. Sports Sci. 2015,33,1814-1821. [CrossRef] [PubMed]
6. Van Wick,K.; Lenaerts,K.; van Loon,L.J.C.; Peters,W.H.M.; Buurman,W.A.; Dejong,C.H.C. Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. PLoS ONE 2011,6,e22366. [CrossRef] [PubMed]
7. Pals,K.L.; Ray-Tai,C.; Ryan,A.J.; Gisolfi,C.V. Effect of running intensity on intestinal permeability. J. Appl. Physiol. 1997,82,571-576. [PubMed]
8. Zuhl,M.; Schneider,S.; Lanphere,K.; Conn,C.; Dokladny,K.; Mosely,P. Exercise regulation of intestinal tight junction proteins. Br. J. Sports Med. 2014,48,980-986. [CrossRef] [PubMed]
9. Jeukendrup,A.E.; Vet-Joop,K.; Sturk,A.; Stegen,J.H.J.C.; Senden,J.; Saris,W.H.M.;Wagenmakers,A.J.M. Relationship between gastro-intestinal complaints and endotoxemia,cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin. Sci. 2000,98,47-55. [CrossRef] [PubMed]
10. Brock-Utne,J.G.; Gaffin,S.L.; Wells,M.T.; Gathiram,P.; Sohar,E.; James,M.F.; Morrell,D.F.; Norman,R.J. Endotoxemia in exhausted runners after a long-distance race. S. Afr. Med. J. 1988,73,533-536. [PubMed]
11. Guo,Y.; Zhou,G.; He,C.; Yang,W.; He,Z.; Liu,Z. Serum levels of lipopolysaccharide and 1,3-β-D-Glucan refer to the severity in patients with Crohn’s disease. Mediat. Inflamm. 2015,2015,843089. [CrossRef] [PubMed]
12. Opal,S.M.; Scannon,P.J.; Vincent,J.-E.; White,M.; Carroll,S.F.; Palardy,J.E.; Parejo,N.A.; Pribble,J.P.; Lemke,J.H. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J. Infect. Dis. 1999,180,1584-1589. [CrossRef] [PubMed]
13. Selkirk,G.A.; McLellan,T.M.;Wright,H.E.; Rhind,S.G. Mild endotoxemia,NF-κB translocation,and cytokine increase during exertional heat stress in trained and untrained individuals. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008,295,R611-R623. [CrossRef] [PubMed]
14. Yeh,Y.J.; Law,L.Y.L.; Lim,C.L. Gastrointestinal response and endotoxemia during intense exercise in hot and cool environments. Eur. J. Appl. Physiol. 2013,113,1575-1583. [CrossRef] [PubMed]
15. Gill,S.K.; Teixeira,A.; Rama,L.; Rosado,F.; Hankey,J.; Scheer,V.; Hemmings,K.; Ansley-Robson,P.; Costa,R.J.S. Circulatory endotoxin concentration and cytokine profile in response to exertional-heat stress during a multi-stage ultra-marathon competition. Exerc. Immunol. Rev. 2015,21,114-128. [PubMed]
16. Maitra,U.; Deng,H.; Glaros,T.; Baker,B.; Capelluto,D.G.S.; Li,Z.; Li,L. Molecular mechanisms responsible for the selective low-grade induction of pro-inflammatory mediators in murine macrophages by lipopolysaccharide. J. Immunol. 2012,189,1014-1023. [CrossRef] [PubMed]
17. Tuohy,K.M.; Probert,H.M.; Smejkal,C.W.; Gibson,G.R. Using probiotics and prebiotics to improve gut health. Drug Discov. Today 2003,8,692-700. [CrossRef]
18. Gareau,M.G.; Sherman,P.M.;Walker,W.A. Probiotics and the gut microbiota in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. 2010,7,503-514. [CrossRef] [PubMed]
19. Martin,R.; Miquel,S.; Ulmer,J.; Kechaou,N.; Langella,P.; Bermudez-Humaran,L. Role of commensal and probiotic bacteria in human health: A focus on inflammatory bowel disease. Microb. Cell Fact. 2013,12,71. [CrossRef] [PubMed]
20. West,N.P.; Pyne,D.B.; Cripps,A.W.; Hopkins,W.G.; Eskesen,D.C.; Jairath,A.; Christophersen,C.T.; Conlon,M.A.; Fricker,P.A. Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: A randomised control trial in athlete. Nutr. J. 2011,10,30. [CrossRef] [PubMed]
21. Gleeson,M.; Bishop,N.C.; Oliveira,M.; Tauler,P. Daily probiotic’s (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int. J. Sports Nutr. Exerc. Metabol. 2011,21,55-64. [CrossRef]
22. Nageo,F.; Nakayama,M.; Muto,T.; Okumura,K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci. Biotechnol. Biochem. 2000,64,2706-2708. [CrossRef]
23. Jager,R.; Purpura,M.; Stone,J.D.; Turner,S.M.; Anzalone,A.J.; Eimerbrink,M.J.; Pane,M.; Amoruso,A.; Rowlands,D.S.; Oliver,J.M. Probiotic Streptococcus thermophilus FP4 and Bifidobacterium breve BR03 supplementation attenuates performance and range-of-motion decrements following muscle damaging exercise. Nutrients 2016,8,E642. [CrossRef] [PubMed]
24. Williams,E.A.; Stimpson,J.; Wang,D.; Plummer,S.; Garaiova,I.; Barker,M.E.; Corfe,B.M. Clinical trial: A multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment. Pharmacol. Ther. 2008,29,97-103. [CrossRef] [PubMed]
25. Plummer,S.F.; Garaiova,I.; Sarvotham,T.; Cottrell,S.L.; Le Scouiller,S.; Weaver,M.A.; Tang,J.; Dee,P.; Hunter,J. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int. J. Antimicrob. Agents 2005,26,69-74. [CrossRef] [PubMed]
26. Lamprecht,M.; Bogner,S.; Schippinger,G.; Steinbauer,K.; Fankhauser,F.; Hallstroem,S.; Schuetz,B.; Greilberger,J.F. Probiotic supplementation affects markers of intestinal barrier,oxidation,and inflammation in trained men; a randomized,double-blinded,placebo-controlled trial. J. Int. Soc. Sports Nutr. 2012,9,45. [CrossRef] [PubMed]
27. Topping,D.L.; Clifton,P.M. Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 2001,81,1031-1064. [PubMed]
28. Ashton,T.; Young,I.S.; Davison,G.W.; Rowlands,C.C.; McEneny,J.; Van Blerk,C.; Jones,E.; Peters,J.R.; Jackson,S.K. Exercise-induced endotoxemia: The effect of ascrobic acid supplementation. Free Radic. Biol. Med. 2003,35,284-291. [CrossRef]
29. Suzuki,T.; Hara,H. Quercitin enhances intestinal barrier function through the assembly of zonnula occludens-2,occludin,and claudin-1 and the expression of claudin-4 in caco-2 cells. J. Nutr. 2009,139,965-974. [CrossRef] [PubMed]
30. Bereswill,S.; Munoz,M.; Fischer,A.; Plickert,R.; Haag,L.-M.; Otto,B.; Kuhl,A.A.; Loddenkemper,C.; Gobel,U.B.; Heimsaat,M.M. Anti-inflammatory effects of resveratrol,curcumin and simvastatin in acute small intestinal inflammation. PLoS ONE 2010,5,e15099. [CrossRef] [PubMed]
31. Hussein,S.A.; El-Senosy,Y.A.; Hassan,M.F. Gastro protective,antiapoptotic and anti-inflammatory effect of alpha-lipoic acid on ethanol induced gastric mucosal lesions in rats. Am. J. Biochem. Mol. Biol. 2014,4,48-63. [CrossRef]
32. Sung,M.J.; Kim,W.; Ahn,S.Y.; Cho,C.-H.; Koh,G.Y.; Moon,S.-O.; Kim,D.H.; Lee,S.; Kang,K.P.; Jang,K.Y.; et al. Protective effect of α-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression. Circ. Res. 2005,97,880-890. [CrossRef] [PubMed]
33. Zembron-Lacny,A.; Slowinska-Lisowska,M.; Szygula,Z.; Witkowski,K.; Stefaniak,T.; Dziubek,W. Assessment of the antioxidant effectiveness of α-lipoic acid in healthy men exposed to muscle-damaging exercise. J. Physiol. Pharmacol. 2009,60,139-143. [PubMed]
34. Faul,F.; Erdfelder,E.; Lang,A.-G.; Buchner,A. G*power 3: A flexible statistical power analysis program for the social,behavioral,and biomedical sciences. Behav. Res. Methods 2007,39,175-191. [CrossRef] [PubMed]
35. Johnston,S.D.; Smye,M.;Watson,R.G.P.; McMillan,S.A.; Trimble,E.R.; Love,A.H.G. Lactulose-mannitol intestinal permeability test: A useful screening test for adult coeliac disease. Ann. Clin. Biochem. 2000,37,512-519. [PubMed]
36. Foster,C.; Florhaug,J.A.; Franklin,J.; Gottschall,L.; Hrovatin,L.A.; Parker,S.; Doleshal,P.; Dodge,C. A new approach to monitoring exercise training. J. Strength Cond. Res. 2001,15,109-115. [CrossRef] [PubMed]
37. Comyns,T.; Flanagan,E.P. Applications of the session rating of perceived exertion system in professional rugby union. Strength Cond. J. 2013,35,78-85. [CrossRef]
38. Jentjens,R.L.P.G.;Wagenmakers,A.J.M.; Jeukendrup,A.E. Heat stress increases muscle glycogen use but reduces the oxidation of ingested carbohydrates during exercise. J. Appl. Physiol. 2002,92,1562-1572. [CrossRef] [PubMed]
39. Nadhazi,Z.; Takats,A.; Offenmuller,K.; Bertok,L. Plasma endotoxin level of healthy donors. Acta Microbiol. Immunol. Hung. 2002,49,151-157. [CrossRef] [PubMed]
40. Hurley,J.C. Endotoxemia: Methods of detection and clinical correlates. Clin. Microbiol. Rev. 1995,8,268-292. [PubMed]
41. Flynn,M.G.; McFarlin,B.K. Toll-like receptor 4: Link to the anti-inflammatory effects of exercise? Exerc. Sport Sci. Rev. 2006,34,176-181. [CrossRef] [PubMed]
42. Stuempfle,K.J.; Valentino,T.; Hew-Butler,T.; Hecht,F.M.; Hoffman,M.D. Nausea is associated with endotoxemia during a 161-km ultramarathon. J. Sports Sci. 2016,34,1662-1668. [CrossRef] [PubMed]
43. Sharma,B.; Srivastava,S.; Singh,N.; Sachdev,V.; Kapur,S.; Saraya,A. Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: A double-blind randomised controlled trial. J. Clin. Gastroenterol. 2011,45,442-448. [CrossRef] [PubMed]
44. Greco,L.; D’Adamo,G.; Truscelli,A.; Parrilli,G.; Mayar,M.; Budillon,G. Intestinal permeability after single dose gluten challenge in coeliac disease. Arch. Dis. Child. 1991,66,870-872. [CrossRef] [PubMed]
45. Van Elburg,R.M.; Uil,J.J.; Kokke,F.T.M.; Mulder,A.M.; van de Broek,W.G.M.; Mulder,C.J.J.; Heymans,H.S.A. Repeatibility of the sugar-absorption test,using lactulose and mannitol,for measuring intestinal permeability for sugars. J. Pediatr. Gastroenterol. Nutr. 1995,20,184-188. [CrossRef] [PubMed]
46. Rosenfeldt,V.; Benfeldt,E.; Valerius,N.H.; Paerregaard,A.; Michaelsen,K.F. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J. Pediatr. 2004,145,612-616. [CrossRef] [PubMed]
47. Cox,A.J.; Pyne,D.B.; Saunders,P.U.; Fricker,P.A. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br. J. Sports Med. 2010,44,222-226. [CrossRef] [PubMed]
48. Ulluwishewa,D.; Anderson,R.C.; McNabb,W.C.; Moughan,P.J.; Wells,J.M.; Roy,N.C. Regulation of tight junction permeability by intestinal bacteria and dietary components. J. Nutr. 2011,141,769-776. [CrossRef] [PubMed]
49. Gill,S.K.; Allerton,D.M.; Ansley-Robson,P.; Hemmings,K.; Cox,M.; Costa,R.J.S. Does short-term high dose probiotic supplementation containing Lactobacillus casei attenuate exertional-heat stress induced endotoxemia and cytokinaemia? Int. J. Sport Nutr. Exerc. Metab. 2016,26,268-275. [CrossRef] [PubMed]
50. Munford,R.S. Sensing gram-negative bacterial lipopolysaccharides: A human disease determinant? Infect. Immun. 2008,76,454-465. [CrossRef] [PubMed]
51. Mach,N.; Botella-Fuster,D. Endurance exercise and gut microbiota: A review. J. Sports Health Sci. 2016,in press. [CrossRef]
52. Nakamura,Y.K.; Omaye,S.T. Metabolic disease and pro- and prebiotics: Mechanistic insights. Nutr. Metab. 2012,9,60. [CrossRef] [PubMed]
53. Lescheid,D.W. Probiotics as regulators of inflammation: A review. Funct. Foods Health Dis. 2014,4,299-311.
54. Pagnini,C.; Saeed,R.; Bamias,G.; Arseneau,K.O.; Pizarro,T.T.; Cominelli,F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc. Natl. Acad. Sci. USA 2010,107,454-459. [CrossRef] [PubMed]
55. Madden,J.A.J.; Plummer,S.F.; Tang,J.; Garaiova,I.; Plummer,N.T.; Herbison,M.; Hunter,J.O.; Shimada,T.; Cheng,L.; Shirakawa,T. Effects of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: A double-blind,placebo-controlled pilot study. Int. Immunopharmacol. 2005,5,1091-1097. [CrossRef] [PubMed]
56. Plummer,S.; Weaver,M.A.; Harris,J.C.; Dee,P.; Hunter,J. Clostridium difficile pilot study: Effects of probiotic supplementation on the incidence of C. difficile diarrhea. Int. Microbiol. 2004,7,59-62. [PubMed]
57. Dehghan,P.; Gargari,B.P.; Jafar-abadi,A.M. Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized controlled clinical trial. Nutrition 2014,30,418-423. [CrossRef] [PubMed]
58. Rastall,R.A.; Gibson,G.R. Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Curr. Opin. Biotechnol. 2015,32,42-46. [CrossRef] [PubMed]
59. Delzenne,N.M.; Neyrinck,A.M.; Cani,P.D. Gut microbiota and metabolic disorders: How prebiotic can work? Br. J. Nutr. 2013,109 (Suppl 2),S81-S85. [CrossRef] [PubMed]
60. Dewulf,E.M.; Cani,P.D.; Claus,S.P.; Fuentes,S.; Puylaert,P.G.B.; Neyrinck,A.M.; Bindels,L.B.; de Vos,W.M.; Gibson,G.R.; Thissen,J.-P.; et al. Insight into the prebiotic concept: Lessons from an exploratory,double-blind intervention study with inulin-type fructans in obese women. Gut 2013,62,1112-1121. [CrossRef] [PubMed]
61. Rajkumar,H.; Kumar,M.; Das,N.; Kumar,S.N.; Challa,H.R.; Nagpal,R. Effect of probiotic Lactobacillus salivarius UBL S22 and prebiotic fructo-oligosaccharide on serum lipids,inflammatory markers,insulin sensitivity,and gut bacteria in healthy young volunteers: A randomized controlled single-blind pilot study. J. Cardiovasc. Pharmacol. Ther. 2015,20,289-298. [CrossRef] [PubMed]
62. Lindsay,J.O.; Whelan,K.; Stagg,A.J.; Gobin,P.; Al-Hassi,H.O.; Rayment,N.; Kamm,M.A.; Knight,S.C.; Forbes,A. Clinical,microbiological,and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease. Gut 2006,55,348-355. [CrossRef] [PubMed]
63. Nova,E.; Viadel,B.;Warnberg,J.; Carreres,J.E.; Marcos,A. Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults. J. Med. Food 2011,14,79-85. [CrossRef] [PubMed]
64. Khanna,S.; Atalay,M.; Lakksonen,D.E.; Gul,M.; Roy,S.; Sen,C.L. α-lipoic acid supplementation: Tissue glutathione homeostasis at rest and after exercise. J. Appl. Physiol. 1999,86,1191-1196. [PubMed]
65. Shay,K.P.; Moreau,R.F.; Smith,E.J.; Smith,A.R.; Hagen,T.M. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochem. Biophys. Acta 2009,1790,1149-1160. [CrossRef] [PubMed]
66. Heer,M.; Repond,F.; Hany,A.; Sulser,H.; Kehl,O.; Jager,K. Actue ischaemic colitis in a female long distance runner. Gut 1987,28,896-899. [CrossRef] [PubMed]
67. Buffinton,G.D.; Doe,W.F. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic. Biol. Med. 1995,19,911-918. [CrossRef]
68. Goraca,A.; Peichota,A.; Huk-Kolega,H. Effect of alpha-lipoic acid on LPS-induced oxidative stress in the heart. J. Physiol. Pharmacol. 2009,60,61-68. [PubMed]
69. Heibashy,M.I.A.; Mazen,G.M.A.; Shahin,M.I. The curative effects of some antioxidants on endotoxin induced with lipopolysaccharides in the liver of rats. J. Am. Sci. 2013,9,529-538.
70. Zhang,W.-J.;Wel,H.; Hagen,T.; Frel,B. α-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc. Natl. Acad. Sci. USA 2007,104,4077-4082. [CrossRef] [PubMed]
71. Kuennen,M.; Gillum,T.; Doklandy,K.; Bedrick,E.; Schneider,S.; Moseley,P. Thermotolerance and heat acclimcation may share a common mechanism in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011,301,R524-R533. [CrossRef] [PubMed]
72. Prado de Oliveira,E.; Jeukendrup,A. Nutritional recommendations to avoid gastrointestinal complaints during exercise. Sports Sci. Exch. 2013,26,1-4.
73. Pyne,D.B.; West,N.P.; Cox,A.J.; Cripps,A.W. Probitoics supplementation for athletes-Clinical and physiological effects. Eur. J. Sport Sci. 2015,15,63-72. [CrossRef] [PubMed]